Clinical trial NCT05013996: Impact of a Structured Clinical Assessment MIDSA, Its Feedback and Support for Change on Commitment to Care of Perpetrators of Sexual Offenses
Official title: Impact d'un Bilan Clinique structuré (MIDSA), de sa Restitution et de l'Accompagnement au Changement Sur l'Engagement Dans le Soin (évalué Par l'échelle URICA) d'Auteurs d'Infraction à caractère Sexuel : Essai contrôlé randomisé Multicentrique en Ouvert
Study type: INTERVENTIONAL
Overall status: RECRUITING
Phase: NA
Conditions: Offense, Sex
Keywords: sexual offenders;MIDSA
Lead sponsor: University Hospital, Tours
Sponsor class: OTHER
First posted: 2021-08-20
Enrollment: 200
Sex: MALE
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Intervention model description: open label multicenter randomized controlled trial
Primary purpose: HEALTH_SERVICES_RESEARCH

Brief summary: Evaluate the effectiveness of an intervention including the clinical assessment carried out with the (Multidimensional Inventory of Development, Sex, and Aggression) MIDSA and the review of the results with the professional in charge of the subject on the adherence and commitment to the care of the sexual offenders.

Detailed description: The intervention of MIDSA (Multidimensional Inventory of Development, Sex, and Aggression), a multidimensional investigation tool for issues related to sexuality and violence, could be prove very useful by providing AICS patients as well as the professionals who take care of them with a complete clinical assessment which enlightens the patient on his psychopathological functioning and / or his disorders, and which guides the care through the axes of intervention to be implemented in response to the criminological and non-criminological needs of the patient. This should allow the latter a better awareness (awareness) of his difficulties in the relationship with the other, facilitate his adherence to care, obtain a better commitment on his part in the process of change and consequently, bring him change their lifestyle and gradually adopt proactive attitudes and behavior that ultimately reduce the risk of recidivism of sexual and general violence. However, recourse to MIDSA as a "change operator" in a patient's trajectory is only possible if it is accompanied by a resumption of his clinical assessment by a professional who supports the change process by strengthening his motivation to change their criminal behavior.

Eligibility criteria: Inclusion Criteria:

* Adult male patients
* Express written consent of the participant after receiving the study information
* Subject making contact or being taken in charge by a psychiatric service (even an addictology service or by liberal practitioners in connection with psychiatry), a CRIAVS or a care unit dedicated to the care of perpetrators of a sexual offense (AICS) ;
* For a problem of sexual violence such as sexual harassment, assault and rape of adult women (including marital rape), incest, pedophilic or hebephilic acts, sexual sadism, exhibition, voyeurism, frotteurism, use and possession of child pornography or addiction sexual.

  * Affiliated to a social security scheme

Exclusion Criteria:

* Maximum stage (maintenance phase) listed on the URICA scale
* Poor understanding of the French language;
* Patient imprisoned, under legal protection, under guardianship or curatorship

Primary outcomes:
measure: Change in behavior
timeFrame: up to 6 months
Secondary outcomes:
measure: Assessment of the risk for sexual violence (RSVP)
timeFrame: up to 1 year
measure: Assessment of the risk of violence (in general) and the risk factors of the sexual offenders
timeFrame: up to 1 year
measure: Assessment of the multidimensional self-esteem assessment (SEI)
timeFrame: up to 1 year
measure: Quality of life assessment
timeFrame: up to 1 year
measure: Assessment of social desirability will be carried out by the MCSDS
timeFrame: up to 1 year
measure: Assessment of Risk factors and protective factors against violence
timeFrame: up to 1 year
Other outcomes:
Locations:
city: Lille
country: France
facility: CHRU Lille - URSAVS Lille
city: Lyon
country: France
facility: CH LE Vinatier - Service de Psychiatrie Légale
city: Montpellier
country: France
facility: CHU Montpellier Lapeyronie - CRIAVS Languedoc-Roussillon
city: Poitiers
country: France
facility: CHU Poitiers Henri Laborit - CRIAVS - CMP Espace Vienne - SMPR
city: Tours
country: France
facility: CHRU Tours - UC3P
Study officials:
affiliation: University Hospital of TOURS
name: Robert COURTOIS, MD-PhD
role: STUDY_DIRECTOR
References: